background
patient
idiopath
pulmonari
fibrosi
ipf
often
experi
acut
exacerb
ae
episod
common
cold
aim
establish
mous
model
viru
infectioninduc
aeipf
investig
mechan
underli
aeipf
method
herp
simplex
viru
inocul
intranas
wildtyp
wt
gene
knockout
mice
day
intratrach
administr
bleomycin
blm
result
infect
caus
acut
exacerb
mice
blminduc
fibrosi
compar
blmsalin
mice
mice
show
significantli
higher
acut
lung
injuri
ali
score
p
lower
surviv
rate
vs
p
poorer
lung
function
higher
inflammatori
respons
repres
increas
total
inflammatori
cell
bronchoalveolar
lavag
fluid
balf
p
increas
proport
cell
peripher
blood
p
higher
inflammatori
factor
balf
addit
infect
increas
express
endoplasm
reticulum
stress
er
relat
protein
mice
blminduc
fibrosi
inhibit
er
tauroursodeoxychol
acid
tudca
er
inhibitor
significantli
reduc
level
balf
p
cell
peripher
blood
p
mice
suggest
suppress
er
may
reduc
respons
mice
aeipf
compar
wt
mice
mice
lower
ali
score
p
higher
surviv
rate
vs
p
improv
lung
function
milder
inflammatori
respons
conclus
infect
addit
blminduc
ipf
success
establish
aeipf
mice
er
promot
lung
inflamm
aeipf
develop
k
e
w
r
acut
exacerb
idiopath
pulmonari
fibrosi
endoplasm
reticulum
stress
herp
simplex
viru
tao
chen
hui
qiu
mengmeng
zhao
contribut
equal
work
idiopath
pulmonari
fibrosi
ipf
chronic
progress
fibrot
interstiti
pneumonia
unknown
aetiolog
median
surviv
time
year
natur
cours
ipf
show
sever
clinic
characterist
slow
progress
longterm
stabl
stage
acut
exacerb
ipf
aeipf
approxim
patient
ipf
develop
aeipf
within
year
clinic
present
aeipf
character
acut
respiratori
difficulti
within
day
lung
histopatholog
show
diffus
alveolar
damag
addit
fibrosi
mortal
rate
median
surviv
time
month
aeipfassoci
death
account
total
death
patient
ipf
thu
aeipf
lead
caus
death
patient
ipf
whether
infect
induc
aeipf
remain
elus
analys
use
panvir
microarray
multiplex
polymeras
chain
reaction
found
common
respiratori
virus
respiratori
track
patient
aeipf
cytomegaloviru
respiratori
syncyti
viru
parainfluenza
viru
rhinoviru
coronaviru
previou
epidemiolog
studi
shown
aeipf
occur
frequent
winter
spring
patient
use
immunosuppress
indic
viru
infect
may
critic
factor
contribut
aeipf
studi
use
anim
model
also
demonstr
mammal
herp
viru
infect
addit
lung
fibrosi
exacerb
lung
fibrosi
howev
anim
model
infectioninduc
aeipf
establish
serious
limit
investig
biolog
mechan
therapeut
intervent
aeipf
previou
studi
use
twice
intratrach
administr
bleomycin
blm
success
establish
mous
model
noninfectioninduc
aeipf
found
level
balf
mice
blmblminduc
aeipf
increas
significantli
compar
mice
stabl
blminduc
ipf
intraperiton
inject
antibodi
allevi
lung
inflamm
mice
current
studi
aim
use
human
herp
simplex
viru
scienc
viral
titr
use
current
studi
base
previou
studi
mix
dmem
media
intranas
inocul
mous
group
inocul
intranas
suspens
four
time
mous
salinesalin
blmsalin
group
administ
equal
volum
salin
accord
descript
keestragound
et
al
mous
group
receiv
daili
intraperiton
inject
tudca
mgkg
sigmaaldrich
darmstadt
germani
intranas
inocul
bronchoalveolar
lavag
fluid
balf
collect
day
day
blm
administr
day
day
blm
administr
centrifug
g
minut
supernat
harvest
store
futur
experi
left
lung
tissu
frozen
part
right
lung
tissu
use
determin
wet
dri
weight
ratio
remain
right
lung
tissu
fix
standard
tissu
fixat
solut
wuhan
goodbio
technolog
co
ltd
wuhan
china
hematoxylin
eosin
h
e
masson
stain
mice
use
collect
balf
lung
tissu
two
batch
experi
model
way
therefor
lung
tissu
use
wet
dri
ratio
histopatholog
perfus
salin
hour
fixat
paraembed
lung
tissu
section
prepar
use
h
e
masson
stain
stain
tissu
section
scan
leica
slide
scanner
leica
accord
report
mikawa
et
al
acut
lung
injuri
ali
score
h
e
stain
tissu
section
determin
masson
stain
score
determin
follow
criteria
chen
et
al
estim
lung
fibrosi
sever
develop
ashcroft
et
al
two
pathologist
extens
experi
determin
ali
score
masson
stain
score
independ
averag
score
use
twentyon
day
intratrach
administr
blm
wt
mice
mice
random
blmsalin
group
total
four
group
wtblmsalin
blmsalin
blm
mous
surviv
record
start
infect
day
week
till
day
balf
supernat
centrifug
g
min
remov
precipit
supernat
harvest
protein
content
measur
bicinchonin
acid
bca
assay
micropl
reader
biotek
instrument
inc
winooski
vt
use
read
bca
assay
result
wavelength
nm
wet
weight
middl
lobe
right
lung
measur
dri
weight
measur
lung
tissu
dri
vacuum
freez
dryer
beij
sihuan
compani
beij
china
overnight
wetdri
weight
ratio
wet
weight
dri
weight
lung
tissu
homogen
tissu
homogen
lyse
thoroughli
tissu
lysat
centrifug
supernat
collect
protein
concentr
supernat
determin
bca
assay
sampl
equal
amount
protein
load
sdspolyacrylamid
gel
electrophoresi
protein
transfer
pvdf
membran
membran
probe
polyclon
antimous
antibodi
activ
transcript
factor
activ
transcript
factor
ccaatenhanc
bind
protein
cebp
homolog
protein
chop
antibodi
purchas
abcam
membran
probe
secondari
antibodi
chemiluminesc
signal
develop
signal
intens
measur
statist
analysi
softwar
graphpad
use
data
analys
continu
variabl
present
mean
standard
deviat
twogroup
comparison
analys
independ
sampl
test
multigroup
comparison
analys
oneway
anova
fisher
lsd
test
kaplanmeri
method
use
plot
surviv
curv
surviv
time
compar
logrank
test
p
consid
statist
signific
figur
b
lung
tissu
inflamm
group
wors
wtblmsalin
worst
day
day
mice
present
typic
aeipf
characterist
includ
alveolar
septal
congest
oedema
inflammatori
cell
infiltr
lung
tissu
alveolar
epitheli
damag
appar
transpar
membran
structur
alveolar
caviti
figur
mice
show
less
inflammatori
cell
infiltr
lung
tissu
mice
figur
group
significantli
higher
ali
score
blmsalin
group
p
figur
mice
show
significantli
lower
ali
score
mice
p
figur
mice
develop
sever
inflamm
form
dens
aggreg
inflammatori
cell
week
infect
look
like
fibrosi
foci
thu
masson
stain
seem
mice
might
develop
sever
fibrosi
wtblmsalin
mice
figur
fibrosi
score
statist
significantli
differ
figur
addit
hydroxyprolin
content
measur
also
demonstr
similar
result
figur
data
suggest
infect
may
stimul
acut
lung
damag
shortterm
may
exacerb
blminduc
fibrosi
substanti
addit
infect
alon
also
caus
acut
inflamm
lung
tissu
figur
surviv
wt
mice
observ
day
day
inocul
intranas
week
day
inflamm
surround
fibrot
tissu
sever
group
inflammatori
cell
infiltr
lung
tissu
reduc
c
mous
lung
tissu
ali
score
repres
imag
masson
stain
magnif
scale
bar
collagen
deposit
peribronchi
area
alveolar
septum
wt
blm
salin
administ
intratrach
mice
day
blm
administr
salin
solut
inocul
intranas
mice
day
day
mous
lung
tissu
collect
h
e
masson
stain
n
group
e
mous
lung
tissu
fibrosi
score
f
surviv
rate
wt
blmsalin
group
n
group
surviv
observ
p
p
p
p
ns
signific
chen
et
al
surviv
rate
mice
significantli
lower
wtblmsalin
group
figur
notabl
surviv
rate
mice
significantli
higher
mice
p
figur
total
protein
balf
significantli
increas
blmsalin
group
figur
lung
tissu
wetdri
weight
ratio
figur
compar
mice
mice
significantli
reduc
total
protein
balf
p
figur
lung
tissu
wetdri
weight
ratio
figur
data
indic
infect
caus
lung
oedema
alveolar
epitheli
damag
protein
leakag
alveoli
appear
attenu
advers
effect
infect
day
fvc
group
decreas
significantli
compar
blmsalin
group
figur
cdyn
remain
similar
two
group
p
figur
infect
day
fvc
cdyn
group
reduc
significantli
compar
blmsalin
group
extent
lung
function
deterior
significantli
milder
mice
mice
balf
significantli
higher
group
f
g
u
r
e
infect
addit
blminduc
lung
fibrosi
impair
alveolar
structur
lung
function
total
protein
balf
day
p
day
p
total
protein
balf
significantli
higher
group
blmsalin
group
b
lung
tissu
wetdri
weight
ratio
day
lung
oedema
sever
group
ratio
smaller
group
group
p
c
fvc
day
p
day
p
fvc
lower
group
blmsalin
group
fvc
higher
group
group
p
cdyn
day
cdyn
lower
group
blmsalin
group
p
better
group
group
p
statist
analysi
lung
function
n
group
statist
analys
n
group
p
p
p
p
ns
signific
fvc
forc
vital
capac
cdyn
dynam
pulmonari
complianc
blmsalin
group
figur
neutrophil
figur
lymphocyt
figur
recruit
appar
blmtreat
mice
indic
inflammatori
monocyt
neutrophil
lymphocyt
recruit
lung
may
associ
acut
lung
damag
three
group
figur
proport
cell
also
significantli
increas
blmsalin
group
p
figur
day
mice
significantli
fewer
lymphocyt
figur
inflammatori
monocyt
neutrophil
figur
balf
mice
result
indic
acut
lung
damag
could
associ
inflammatori
monocyt
neutrophil
chemotaxi
toward
lung
figur
blmsalin
mice
tudca
inhibitor
er
use
tudca
treat
mice
group
express
significantli
lower
level
p
chop
p
p
mice
data
indic
er
may
activ
blminduc
lung
fibrosi
stimul
infectioninduc
aeipf
tudca
attenu
er
aeipf
model
product
attenu
lung
tissu
damag
aeipf
h
e
stain
reveal
group
show
less
inflammatori
cell
infiltr
alveolar
septum
figur
milder
lung
tissu
inflamm
lower
ali
score
figur
group
wherea
sever
lung
fibrosi
remain
similar
two
group
figur
balf
group
contain
significantli
fewer
inflammatori
monocyt
neutrophil
figur
lower
proport
cell
peripher
blood
figur
reduc
level
figur
gcsf
kc
figur
compar
balf
group
result
support
tudca
attenu
acut
lung
injuri
molecular
mechan
underli
benefici
effect
may
associ
inhibit
respons
product
howev
operationinduc
aeipf
occur
rare
patient
current
studi
establish
aeipf
mous
model
use
f
g
u
r
e
er
activ
lung
tissu
mice
aeipf
repres
imag
immunoblot
bd
protein
densitometri
analysi
b
chop
c
express
three
protein
group
significantli
higher
four
group
salin
solut
administ
intranas
mice
day
intratrach
administr
blm
one
group
mice
administr
tudca
infect
day
protein
extract
lung
tissu
antimous
chop
actin
antibodi
use
immunoblot
assay
protein
signal
visual
chemiluminesc
n
group
p
p
p
p
ns
signific
viru
infect
human
easili
infect
mice
alreadi
develop
stabl
blmipf
mous
model
aeipf
better
mimic
aeipf
develop
patient
acut
pulmonari
inflamm
close
correl
proinflammatori
factor
secret
predominantli
cell
lung
tissu
enhanc
inflammatori
respons
f
g
u
r
e
er
inhibitor
tudca
significantli
attenu
acut
inflamm
lung
repres
imag
h
e
stain
group
magnif
scale
bar
tudca
treatment
reduc
inflammatori
cell
infiltr
lung
tissu
affect
extent
lung
fibrosi
b
ali
score
c
masson
stain
fibrosi
score
tudca
treatment
group
show
lower
ali
score
control
group
p
similar
fibrosi
score
e
number
differ
type
inflammatori
cell
balf
tudca
treatment
group
lower
number
neu
im
p
control
group
f
proport
cell
peripher
blood
tudca
treatment
group
show
significantli
less
cell
p
g
h
inflammatori
factor
concentr
balf
tudca
treatment
reduc
concentr
p
p
p
kc
p
gcsf
p
salin
solut
administ
intranas
mice
day
receiv
intratrach
administr
blm
infect
tudca
mgkg
salin
inject
intraperiton
daili
day
lung
tissu
blood
balf
collect
day
infect
n
group
neu
im
neutrophil
inflammatori
monocyt
p
p
p
p
ns
signific
promot
inflammatori
monocyt
neutrophil
chemotaxi
clear
pathogen
effect
howev
excess
inflammatori
respons
may
damag
tissu
neutrophil
inflammatori
monocyt
involv
pathogen
elimin
caus
acut
lung
inflamm
manner
current
studi
data
indic
may
play
import
role
drive
lung
fibrosi
day
mice
respons
bleomycin
treatment
figur
data
seem
contradict
work
wilson
et
al
contain
higher
level
may
promot
pathogen
cell
matur
may
ultim
increas
proport
cell
peripher
blood
far
know
innat
immun
cell
cell
also
produc
innat
primari
immun
respons
preliminari
studi
found
patient
aeipf
higher
level
peripher
blood
patient
stableipf
data
shown
thu
current
studi
focus
role
cell
aeipf
model
current
studi
exclud
effect
produc
cell
cell
compar
wt
mice
mice
might
differ
level
cell
cell
cell
releas
larg
amount
promot
gcsf
kc
secret
gcsf
mobil
neutrophil
bone
marrow
peripher
blood
figur
thu
knockout
appear
partial
reliev
infectioninduc
acut
lung
injuri
mice
result
show
knockout
might
influenc
clearanc
hsv
viru
figur
b
bagri
colleg
also
report
hsv
viral
titr
mice
significantli
differ
wt
mice
genit
hsv
infect
howev
neither
result
bagri
work
actual
measur
lung
work
done
investig
effect
clearanc
hsv
detect
actual
viral
titr
lung
standard
method
plaqu
assay
qrtpcr
futur
hypothes
could
key
mediat
infectioninduc
excess
acut
inflamm
fibrot
lung
er
respons
protein
fold
disrupt
lead
accumul
unfold
protein
endoplasm
reticulum
er
consequ
develop
unfold
protein
respons
upr
er
moder
normal
upr
reduc
accumul
unfold
protein
er
restor
normal
physiolog
function
er
howev
excess
upr
may
trigger
inflammatori
respons
previou
studi
found
concurr
herp
viru
infect
upr
alveolar
epitheli
cell
patient
ipf
suggest
viru
infect
may
contribut
alveolar
epitheli
injuri
exacerb
er
current
studi
found
compar
mice
treat
blmsalin
mice
treat
demonstr
significantli
elev
express
uprrel
protein
particularli
higher
chop
express
lung
tissu
three
signal
pathway
involv
upr
perk
induc
chop
overexpress
studi
overexpress
quit
obviou
mice
treat
jane
colleagu
found
chop
act
transcript
factor
coordin
stimul
express
synergist
previou
studi
demonstr
er
occur
aec
previou
studi
use
alveolar
epitheli
cell
establish
aeipf
cell
model
found
infect
stimul
er
stress
pathway
aec
timeand
dosedepend
manner
current
studi
mice
treat
increas
level
balf
compar
mice
treat
blmsalin
bind
receptor
cell
induc
cell
differenti
cell
consequ
increas
concentr
addit
found
er
inhibit
tudca
proport
cell
mous
peripher
blood
reduc
concentr
balf
decreas
acut
lung
injuri
also
attenu
find
indic
inhibit
er
allevi
lung
inflamm
probabl
take
effect
reduc
product
howev
previou
studi
respiratori
syncyti
viru
infect
anim
model
suggest
er
lung
tissu
increas
result
cleavag
matur
product
enhanc
secret
might
account
aggrav
inflamm
report
lpsinduc
acut
lung
injuri
er
activ
promot
kind
cytokin
secret
kc
gcsf
till
studi
identifi
pathway
play
critic
role
work
done
explor
relationship
er
stress
inflamm
addit
studi
also
suggest
antibodi
treatment
gene
knockout
allevi
upr
lung
tissu
substanti
support
may
promot
er
lung
tissu
figur
studi
success
establish
infectioninduc
aeipf
mice
blminduc
lung
fibrosi
found
er
play
key
role
acut
lung
injuri
aeipf
studi
provid
anim
model
aeipf
highli
mimic
human
aeipf
facilit
investig
aetiolog
pathogen
mechan
intervent
aeipf
author
thank
professor
chen
wang
conceiv
studi
offer
help
experi
author
confirm
conflict
interest
studi
approv
institut
ethic
committe
shanghai
pulmonari
hospit
http
